Patents by Inventor Purvi Shah

Purvi Shah has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Cell cycle and proliferation proteins
    Publication number: 20050048623
    Abstract: The invention provides human cell cycle and proliferation proteins (CCYPR) and polynucleotides which identify and encode CCYPR. The invention also provides expression vectors, host cells, antibodies, agonists, and antagonists. The invention also provides methods for diagnosing, treating, or preventing disorders associated with expression of CCYPR.
    Type: Application
    Filed: October 6, 2004
    Publication date: March 3, 2005
    Inventors: Jennifer Hillman, Preeti Lal, Y. Tang, Henry Yue, Janice Au-Young, Olga Bandman, Yalda Azimzai, Junming Yang, Dyung Lu, Mariah Baughn, Chandra Arvizu, Purvi Shah
  • Two human heat shock protein homolgs
    Publication number: 20050037461
    Abstract: The invention provides two human heat shock protein homologs (HSPHH-1, HSPHH-2) and polynucleotides which identify and encode HSPHH-1 and HSPHH-2. The invention also provides expression vectors, host cells, agonists, antibodies and antagonists. The invention also provides methods for treating disorders associated with expression of HSPHH-1 and HSPHH-2.
    Type: Application
    Filed: June 21, 2004
    Publication date: February 17, 2005
    Inventors: Jennifer Hillman, Purvi Shah, Neil Corley, Preeti Lal
  • Human protease molecules
    Patent number: 6855811
    Abstract: The invention provides human protease molecules (HUPM) and polynucleotides which identify and encode HUPM. The invention also provides expression vectors, host cells, antibodies, agonists, and antagonists. The invention also provides methods for treating or preventing disorders associated with expression of HUPM.
    Type: Grant
    Filed: September 26, 2001
    Date of Patent: February 15, 2005
    Assignee: Incyte Pharmaceuticals, Inc.
    Inventors: Olga Bandman, Jennifer L. Hillman, Henry Yue, Karl J. Guegler, Neil C. Corley, Y. Tom Tang, Purvi Shah
  • Human lysophospholipase
    Patent number: 6838245
    Abstract: The present invention provides a human lysophospholipase (NHLP) and polynucleotides which identify and encode NHLP. The invention also provides expression vectors, host cells, agonists, antibodies and antagonists. In addition, the invention provides methods for producing NHLP and for treating or preventing disorders associated with expression of NHLP.
    Type: Grant
    Filed: November 19, 2001
    Date of Patent: January 4, 2005
    Assignee: Incyte Corporation
    Inventors: Jennifer L. Hillman, Purvi Shah, Lynn E. Murry
  • Glutathione S-transferase
    Patent number: 6806071
    Abstract: The invention provides a human new glutathione S-transferase (GSTS) and polynucleotides which identify and encode GSTS. The invention also provides expression vectors, host cells, agonists, antibodies and antagonists. The invention also provides methods for treating disorders associated with expression of GS.
    Type: Grant
    Filed: November 16, 1999
    Date of Patent: October 19, 2004
    Assignee: Incyte Corporation
    Inventors: Jennifer L. Hillman, Preeti Lal, Neil C. Corley, Purvi Shah
  • Human regulatory proteins
    Publication number: 20040203109
    Abstract: The invention provides human regulatory proteins and polynucleotides (collectively designated NHRP) which identify and encode them. The invention also provides expression vectors, host cells, agonists, antibodies and antagonists. The invention further provides methods for diagnosing and treating disorders associated with expression of human regulatory proteins.
    Type: Application
    Filed: May 10, 2004
    Publication date: October 14, 2004
    Applicant: Incyte Corporation
    Inventors: Preeti Lal, Olga Bandman, Jennifer L. Hillman, Purvi Shah, Neil C. Corley
  • Human preproneurotensin/neuromedin N
    Publication number: 20040086936
    Abstract: The invention provides a human preproneurotensin/neuromedin N (HPPN) and polynucleotides which identify and encode HPPN. The invention also provides expression vectors, host cells, antibodies, agonists, and antagonists. The invention also provides methods for treating or preventing disorders associated with expression of HPPN.
    Type: Application
    Filed: August 9, 2001
    Publication date: May 6, 2004
    Applicant: Incyte Pharmaceuticals, Inc
    Inventors: Preeti Lal, Purvi Shah, Neil C. Corley
  • Molecules for diagnostics and therapeutics
    Publication number: 20040048253
    Abstract: The present invention provides purified human polynucleotides for diagnostics and therapeutics (dithp). Also encompassed are the polypeptides (DITHP) encoded by dithp. The invention also provides for the use of dithp, or complements, oligonucleotides, or fragments thereof in diagnostic assays. The invention further provides for vectors and host cells containing dithp for the expression of DITHP. The invention additionally provides for the use of isolated and purified DITHP to induce antibodies and to screen libraries of compounds and the use of anti-DITHP antibodies in diagnostic assays. Also provided are microarrays containing dithp and methods of use.
    Type: Application
    Filed: June 5, 2003
    Publication date: March 11, 2004
    Inventors: Scott R. Panzer, Peter A. Spiro, Steven C. Banville, Purvi Shah, Michael S. Chalup, Simon C Chang, Alice J. Chen, Steven A. D'Sa, Stefan Amshey, Christopher E. Dahl, Tam C. Dam, Susan E. Daniels, Gerard E. Dufour, Vincent Flores, Willy T. Fong, Lila B. Greenawalt, Jennifer L. Jackson, Anissa L. Jones, Tommy F. Liu, Ann M. Roseberry Lincoln, Bruce H. Rosen, Frank D. Russo, Theresa K. Stockdreher, Abel Daffo, Rachel J. Wright, Pierre E. Yap, Jimmy Y. Yu, Diana L. Bradley, Shawn R. Bratcher, Wensheng Chen, Howard J. Cohen, David M. Hodgson, Stephen E. Lincoln, Stuart E. Jackson
  • Transriotion factors
    Publication number: 20040033942
    Abstract: The invention provides human transcription factors (TRFX) and polynucleotides which identify and encode TRFX. The invention also provides expression vectors, host cells, antibodies, agonists, and antagonists. The invention also provides methods for diagnosing, treating, or preventing disorders associated with expression of TRFX.
    Type: Application
    Filed: February 13, 2003
    Publication date: February 19, 2004
    Inventors: Jennifer L Jackson, Mariah R Baughn, Henry Yue, Preeti G Lal, Dyung Aina M Lu, Chandra S Arvizu, Yalda Azimzai, Olga Bandman, Y Tom Tang, Preete Bhanot, Purvi Shah, Janice Au-Yong
  • Human galactosyltranferases
    Patent number: 6649737
    Abstract: The invention provides human galactosyltransferases (HUGA) and polynucleotides which identify and encode HUGA. The invention also provides expression vectors, host cells, antibodies, agonists, and antagonists. The invention also provides methods for diagnosing, treating, or preventing disorders associated with expression of HUGA.
    Type: Grant
    Filed: August 12, 1999
    Date of Patent: November 18, 2003
    Assignee: Incyte Genomics, Inc.
    Inventors: Jennifer L. Hillman, Karl J. Guegler, Neil C. Corley, Purvi Shah, Chandra Patterson
  • Human galactosyltransferases
    Publication number: 20030203396
    Abstract: The invention provides human galactosyltransferases (HUGA) and polynucleotides which identify and encode HUGA. The invention also provides expression vectors, host cells, antibodies, agonists, and antagonists. The invention also provides methods for diagnosing, treating, or preventing disorders associated with expression of HUGA.
    Type: Application
    Filed: June 10, 2003
    Publication date: October 30, 2003
    Applicant: Incyte Corporation
    Inventors: Jennifer L. Hillman, Karl J. Guegler, Neil C. Corley, Purvi Shah, Chandra Patterson
  • Tumor-associated antigen
    Patent number: 6632617
    Abstract: The invention provides a cDNA which encodes a TUAN. It also provides for the use of the cDNA, fragments, complements, and variants thereof and of the encoded protein, portions thereof and antibodies thereto for diagnosis and treatment of inflammatory and cell proliferative disorders, in particular, Crohn's disease and colon cancer. The invention additionally provides expression vectors and host cells for the production of the protein and a transgenic model system.
    Type: Grant
    Filed: May 14, 2001
    Date of Patent: October 14, 2003
    Assignee: Incyte Corporation
    Inventors: Olga Bandman, Surya K. Goli, Purvi Shah, Neil C. Corley, David G. Streeter
  • Human cathepsin
    Patent number: 6620606
    Abstract: The invention provides a new human cathepsin (LCAP) and polynucleotides which identify and encode LCAP. The invention also provides expression vectors, host cells, agonists, antibodies and antagonists. The invention also provides methods for treating disorders associated with expression of LCAP.
    Type: Grant
    Filed: March 7, 2000
    Date of Patent: September 16, 2003
    Assignee: Incyte Corporation
    Inventors: Olga Bandman, Karl J. Guegler, Neil C. Corley, Purvi Shah
  • Disease associated protein kinases
    Publication number: 20030170219
    Abstract: The invention provides human disease associated protein kinases and polynucleotides (collectively designated DAPK) which identify and encode them. The invention also provides expression vectors, host cells, agonists, antibodies and antagonists. The invention further provides methods for diagnosing and treating disorders associated with expression of human disease associated protein kinases.
    Type: Application
    Filed: January 24, 2001
    Publication date: September 11, 2003
    Applicant: Incyte Pharmaceuticals, Inc.
    Inventors: Olga Bandman, Jennifer L. Hillman, Neil C. Corley, Karl J. Guegler, Preeti Lal, Surya K. Goli, Purvi Shah
  • Human C-type lectin
    Publication number: 20030166136
    Abstract: The present invention provides a new human C-type lectin (CTL-1)) and polynucleotides which encode CTL-1. The invention also provides expression vectors, host cells, agonists, antisense molecules, antibodies, or antagonists. The invention also provides methods for treating disorders associated with expression of CTL-1.
    Type: Application
    Filed: June 24, 2002
    Publication date: September 4, 2003
    Applicant: Incyte Genomics, Inc.
    Inventors: Olga Bandman, Purvi Shah
  • NDR2-related proteins
    Publication number: 20030167480
    Abstract: The invention provides cDNA which encode Ndr2-related proteins. It also provides for the use of the cDNAs, fragments, complements, and variants thereof and of the encoded proteins, portions thereof and antibodies thereto for diagnosis and treatment of cancer, particularly cancers of the intestine, breast, uterus, liver, brain, and kidney. The invention additionally provides expression vectors and host cells for the production of the proteins and a transgenic model system.
    Type: Application
    Filed: June 13, 2002
    Publication date: September 4, 2003
    Applicant: Incyte Genomics, Inc.
    Inventors: Susan G. Stuart, Janice Au-Young, Jennifer L. Hillman, Purvi Shah, Henry Yue
  • Human hydrolase-like molecules
    Publication number: 20030148363
    Abstract: The invention provides human hydrolase-like molecules (HHLM) and polynucleotides which identify and encode HHLM. The invention also provides expression vectors, host cells, antibodies, agonists, and antagonists. The invention also provides methods for treating or preventing disorders associated with expression of HHLM.
    Type: Application
    Filed: February 5, 2003
    Publication date: August 7, 2003
    Applicant: Incyte Genomics, Inc.
    Inventors: Olga Bandman, Preeti Lal, Jennifer L. Hillman, Neil C. Corley, Karl J. Guegler, Purvi Shah
  • Secretory molecules
    Publication number: 20030124569
    Abstract: The present invention provides purified secretory polynucleotides (sptm). Also encompassed are the polypeptides (SPTM) encoded by sptm. The invention also provides for the use of sptm, or complements, oligonucleotides, or fragments thereof in diagnostic assays. The invention further provides for vectors and host cells containing sptm for the expression of SPTM. The invention additionally provides for the use of isolated and purified SPTM to induce antibodies and to screen libraries of compounds and the use of anti-SPTM antibodies in diagnostic assays. Also provided are microarrays containing sptm and methods of use.
    Type: Application
    Filed: August 21, 2002
    Publication date: July 3, 2003
    Inventors: Scott R. Panzer, Peter A. Spiro, Steven C. Banville, Purvi Shah, Michael S. Chalup, Simon C. Chang, Alice Chen, Steven D'sa, Stefan Amshey, Christopher R. Dahl, Tam C. Dam, Susan E. Daniels, Gerard E. Dufour, Vincent Flores, Willy T. Fong, Lila B. Greenawalt, Jennifer L. Hillman, Anissa L. Jones, Tommy F. Liu, Ann M. Roseberry, Bruce H. Rosen, Frank D. Russo, Theresa K. Stockdreher, Abel Daffo, Rachel J. Wright, Pierre E. Yap, Jimmy Y. Yu, Diana L. Bradley, Shawn R. Bratcher, Wensheng Chen, Howard J. Cohen, David M. Hodgson, Stephen E. Lincoln
  • Human phospholipid binding proteins
    Publication number: 20030119730
    Abstract: The invention provides two human phospholipid binding proteins (PLBP) and polynucleotides which identify and encode PLBP. The invention also provides expression vectors, host cells, agonists, antibodies and antagonists. The invention also provides methods for treating and preventing disorders associated with expression of PLBP.
    Type: Application
    Filed: June 11, 2001
    Publication date: June 26, 2003
    Applicant: Incyte Pharmaceuticals, Inc.
    Inventors: Preeti Lal, Jennifer L. Hillman, Neil C. Corley, Purvi Shah
  • Human fatty acid beta-oxidation enzymes
    Publication number: 20030119046
    Abstract: The invention provides human fatty acid beta-oxidation enzymes (HUFA) and polynucleotides which identify and encode HUFA. The invention also provides expression vectors, host cells, antibodies, agonists, and antagonists. The invention also provides methods for treating or preventing disorders associated with expression of HUFA.
    Type: Application
    Filed: December 10, 2002
    Publication date: June 26, 2003
    Applicant: Incyte Genomics, Inc.
    Inventors: Olga Bandman, Jennifer L. Hillman, Karl J. Guegler, Neil C. Corley, Y. Tom Tang, Purvi Shah